Genetic influence of COMT and BDNF gene polymorphisms on resilience in healthy college students

Neuropsychobiology

Volumn 68, Issue 3, 2013, Pages 174-180

  Kang, Jee In ^a   Kim, Se Joo ^a   Song, Yun Young ^a   Namkoong, Kee ^a   An, Suk Kyoon ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Association study; Brain derived neurotrophic factor; Catechol O methyltransferease; Genetic polymorphism; Resilience

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; COLLEGE STUDENT; COPING BEHAVIOR; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANALYSIS OF VARIANCE; CLINICAL ASSESSMENT TOOL; CONNOR DAVIDSON RESILIENCE SCALE; CORRELATION ANALYSIS; GENETIC POLYMORPHISM; HUMAN EXPERIMENT; KOREAN (PEOPLE); NORMAL HUMAN; SEX DIFFERENCE; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84885075030     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000353257     Document Type: Article

References (51)

1. Andreassi JL: Heart activity and behavior. II. Stress, emotions, motivation, personality, social factors, brain interactions, and conditioning; in Psychophysiology: Human Behavior and Physiological Response. Hillsdale, Lawrence Erlbaum, 2007.
2. Richardson GE: The metatheory of resilience and resiliency. J Clin Psychol 2002; 58: 307-321.
3. Bonanno GA: Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am Psychologist 2004; 59: 20-28.
4. Daniels JK, Hegadoren KM, Coupland NJ, Rowe BH, Densmore M, Neufeld RW, Lanius RA: Neural correlates and predictive power of trait resilience in an acutely traumatized sample: a pilot investigation. J Clin Psychiatry 2012; 73: 327-332.
5. Davidson JR, Stein DJ, Rothbaum BO, Pedersen R, Szumski A, Baldwin DS: Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. J Psychopharmacol 2012; 26: 778-783.
6. Waaktaar T, Torgersen S: Genetic and environmental causes of variation in trait resilience in young people. Behav Genet 2012; 42: 366-377.
7. Stein MB, Campbell-Sills L, Gelernter J: Genetic variation in 5HTTLPR is associated with emotional resilience. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:900-906.
8. Feder A, Nestler EJ, Charney DS: Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009; 10: 446-457.
9. Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT: Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007; 27: 10196-10209.
10. Goldman D, Weinberger DR, Malhotra AK, Goldberg TE: The role of COMT Val158Met in cognition. Biol Psychiatry 2009; 65:e1-e2, author reply e3-e4.
11. Tammimaki A, Mannisto PT: Catechol-Omethyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genomics 2012; 22: 673-691.
12. Montag C, Jurkiewicz M, Reuter M: The role of the catechol-O- methyltransferase (COMT) gene in personality and related psychopathological disorders. CNS Neurol Disord Drug Targets 2012; 11: 236-250.
13. Stein MB, Fallin MD, Schork NJ, Gelernter J: COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 2005; 30: 2092-2102.
14. Hettema JM, An SS, Bukszar J, van den Oord EJ, Neale MC, Kendler KS, Chen X: Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 2008; 64: 302-310.
15. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
16. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D: A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159: 652-654.
17. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG: Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci 2005; 17: 1018-1025.
18. Kang JI, Kim SJ, Namkoong K, An SK: Association of DRD4 and COMT polymorphisms with disgust sensitivity in healthy volunteers. Neuropsychobiology 2010; 61: 105-112.
19. Reuter M, Hennig J: Association of the functional catechol-O- methyltransferase Val158Met polymorphism with the personality trait of extraversion. Neuroreport 2005; 16: 1135-1138.
20. Campbell-Sills L, Cohan SL, Stein MB: Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behaviour Res Ther 2006; 44: 585-599.
21. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ: Essential role of bdnf in the mesolimbic dopamine pathway in social defeat stress. Science 2006;311:864-868.
22. Calabrese F, Molteni R, Racagni G, Riva MA: Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009; 34(suppl 1):S208-S216.
23. Pregelj P, Nedic G, Paska AV, Zupanc T, Nikolac M, Balazic J, Tomori M, Komel R, Seler DM, Pivac N: The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord 2011; 128: 287-290.
24. Corominas M, Roncero C, Ribases M, Castells X, Casas M: Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 2007; 55: 2-13.
25. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS: Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140-143.
26. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
27. Montag C, Reuter M, Newport B, Elger C, Weber B: The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage 2008; 42: 1554-1559.
28. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR: The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-10102.
29. Montag C, Weber B, Fliessbach K, Elger C, Reuter M: The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med 2009; 39: 1831-1839.
30. Mukherjee P, Whalley HC, McKirdy JW, Mc-Intosh AM, Johnstone EC, Lawrie SM, Hall J: Effects of the BDNF Val66Met polymorphism on neural responses to facial emotion. Psychiatry Res 2011; 191: 182-188.
31. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
32. Connor KM, Davidson JR: Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 2003; 18: 76-82.
33. Baek HS, Lee KU, Joo EJ, Lee MY, Choi KS: Reliability and validity of the Korean version of the Connor-Davidson Resilience Scale. Psychiatry Investig 2010; 7: 109-115.
34. Cohen H, Buskila D, Neumann L, Ebstein RP: Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002; 46: 845-847.
35. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
36. Frodl T, Schule C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Moller HJ, Meisenzahl EM: Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007; 64: 410-416.
37. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L: New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 2004; 161: 1110-1112.
38. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I: Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 2004; 161: 1703-1705.
39. Chen C, Moyzis R, Dong Q, He Q, Zhu B, Li J, Li H, Lessard J: Sex modulates the associations between the COMT gene and personality traits. Neuropsychopharmacology 2011; 36: 1593-1598.
40. Davidson RT, McLeod MN, White HL, Raft D: Red blood cell catechol O-methyl transferase and response to imipramine in unipolar depressive women. Am J Psychiatry 1976; 133: 952-955.
41. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005; 6: 521-532.
42. Han DH, Park DB, Choi TY, Joo SY, Lee MK, Park BR, Nishimura R, Chu CC, Renshaw PF: Effects of brain-derived neurotrophic factorcatecholamine-O- methyltransferase gene interaction on schizophrenic symptoms. Neuroreport 2008; 19: 1155-1158.
43. Gourion D, Goldberger C, Leroy S, Bourdel MC, Olie JP, Krebs MO: Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 2005; 16: 1407-1410.
44. Kang JI, Song DH, Namkoong K, Kim SJ: Interaction effects between COMT and BDNF polymorphisms on boredom susceptibility of sensation seeking traits. Psychiatry Res 2010; 178: 132-136.
45. Montag C, Markett S, Basten U, Stelzel C, Fiebach C, Canli T, Reuter M: Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val-66Met polymorphism impacts novelty seeking and harm avoidance. Neuropsychopharmacology 2010; 35: 1860-1867.
46. Nagel IE, Chicherio C, Li SC, von Oertzen T, Sander T, Villringer A, Heekeren HR, Backman L, Lindenberger U: Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2008; 2: 1.
47. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381.
48. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ: Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007; 61: 187-197.
49. Aubele T, Kritzer MF: Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats. Cereb Cortex 2011; 21: 222-232.
50. Luine VN: Sex steroids and cognitive function. J Neuroendocrinol 2008; 20: 866-872.
51. Chen H, Pine DS, Ernst M, Gorodetsky E, Kasen S, Gordon K, Goldman D, Cohen P: The MAOA gene predicts happiness in women. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40: 122-125.